Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide

por Le, Yunyi, Yang, Kun, Yang, Jin, Fu, Wei, Xiao, Wenhua, Wei, Rui, Hong, Tianpei
Publicado 2022

Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice

por Wei, Rui, Gu, Liangbiao, Yang, Jin, Yang, Kun, Liu, Junling, Le, Yunyi, Lang, Shan, Wang, Haining, Thai, Dung, Yan, Hai, Hong, Tianpei
Publicado 2019

Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes

por Lang, Shan, Yang, Jin, Yang, Kun, Gu, Liangbiao, Cui, Xiaona, Wei, Tianjiao, Liu, Junling, Le, Yunyi, Wang, Haining, Wei, Rui, Hong, Tianpei
Publicado 2020

Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output

por Liu, Junling, Yang, Kun, Yang, Jin, Xiao, Wenhua, Le, Yunyi, Yu, Fei, Gu, Liangbiao, Lang, Shan, Tian, Qing, Jin, Tianru, Wei, Rui, Hong, Tianpei
Publicado 2019

Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19

por Liu, Ye, Lu, Ran, Wang, Junhong, Cheng, Qin, Zhang, Ruitao, Zhang, Shuisheng, Le, Yunyi, Wang, Haining, Xiao, Wenhua, Gao, Hongwei, Zeng, Lin, Hong, Tianpei
Publicado 2021